CLASS II ONGOING Device recall · Reported 9 Aug 2023 · FDA Enforcement Report

NeuMoDx Cartridge-used for extraction, purification recalled

NeuMoDx Molecular is recalling NeuMoDx Cartridge-used for extraction, purification, amplification and detection of, distributed nationwide in the US. The recall was initiated on 24 May 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesGTIN: 10814278020274 Lot Numbers: 117514, 117524, and 117528
Quantity recalled20,016 cartridges

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2255-2023
FDA event ID
92615
Recalling firm
NeuMoDx Molecular, Ann Arbor, MI
Classification
Class II
Status
Ongoing
Recall initiated
24 May 2023
FDA classified
28 Jul 2023
Reported
9 Aug 2023
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

24 May 2023Recall initiated by company
28 Jul 2023Classified by FDA+65 days
9 Aug 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Top label on some of the NeuMoDx cartridges within these lots may have been incorrectly applied during the manufacturing process, resulting in encroachment into the PCR region. The misplaced label may interfere with the module s optics performance, thereby increasing the risk for false positive results

Product as listed by the FDA

NeuMoDx Cartridge-used for extraction, purification, amplification and detection of nucleic acids on the NeuMoDx 288 and NeuMoDx 96 Molecular Systems (NeuMoDx System(s) Ref: 100100

Where it was distributed

US Nationwide Distribution to states of: Kansas, Florida, Texas, Ohio, New York, Michigan, Pennsylvania; and OUS (Foreign) to countries of: AT, BE, CH, DE, ES, FI, FR, GB, IT, LV, PL, RO, SE

Nationwide DelawareFloridaKansasMichiganNew YorkOhioPennsylvaniaTexas

Questions about this recall

Is NeuMoDx Cartridge-used for extraction, purification, amplification and detection of recalled?

Yes. NeuMoDx Molecular recalled NeuMoDx Cartridge-used for extraction, purification, amplification and detection of on 24 May 2023. The recall is Class II and its status is Ongoing. Recall number Z-2255-2023.

Why was it recalled?

Top label on some of the NeuMoDx cartridges within these lots may have been incorrectly applied during the manufacturing process, resulting in encroachment into the PCR region. The misplaced label may interfere with the module s optics performance, thereby increasing the risk for false positive results

Which lots are affected?

GTIN: 10814278020274 Lot Numbers: 117514, 117524, and 117528

Where was it sold?

US Nationwide Distribution to states of: Kansas, Florida, Texas, Ohio, New York, Michigan, Pennsylvania; and OUS (Foreign) to countries of: AT, BE, CH, DE, ES, FI, FR, GB, IT, LV, PL, RO, SE

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from NeuMoDx Molecular

All 6

Other Other Medical Devices recalls

All 13,778